Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

362.56
Delayed Data
As of Jan 20
 -0.85 / -0.23%
Today’s Change
325.35
Today|||52-Week Range
484.57
-1.23%
Year-to-Date
Top Biotech Stocks to Buy in 2017
2:16pm / MotleyFool.com - Paid Partner Content
Jacobs & Co Buys Praxair Inc, Procter & Gamble Co, Bristol-Myers Squibb Company, Sell...
Jan 18 / GuruFocus News - Paid Partner Content
Regeneron Pharmaceuticals Could Be Ready to Rebound
Jan 20 / TheStreet.com - Paid Partner Content
Prentiss Smith & Co Inc Buys Unilever PLC, Vodafone Group PLC, Verizon Communications...
Jan 18 / GuruFocus News - Paid Partner Content
Georgia Bennicas Dba Bennicas & Associates Buys Kellogg Co, Gilead Sciences Inc, Rege...
Jan 19 / GuruFocus News - Paid Partner Content
5 Biotech Stocks You'll Want to Watch in the 1st Quarter
Jan 18 / MotleyFool.com - Paid Partner Content
Rockefeller Financial Services Inc Buys Facebook Inc, Synchrony Financial, Cemex SAB ...
Jan 19 / GuruFocus News - Paid Partner Content
Key FDA Events to Watch Out for in Q1
Jan 17 / Zacks.com - Paid Partner Content
A Green Light on Bayer
Jan 19 / GuruFocus News - Paid Partner Content
Drugmakers alarmed by Trump pricing threat
Jan 14 / FT.com - Paid Partner Content

Today’s Trading

Previous close363.41
Today’s open365.67
Day’s range362.07 - 369.75
Volume781,954
Average volume (3 months)903,919
Market cap$38.2B
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+79.80%
Earnings growth (this year)-3.72%
Earnings growth (next 5 years)+21.00%
Revenue growth (last year)+45.55%
P/E ratio52.9
Price/Sales15.24
Price/Book10.38

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...-2.38-1.77%
SHPGShire-2.40-1.46%
ZTSZoetis Inc+0.47+0.88%
BAXBaxter International...-0.34-0.73%
Data as of 4:01pm ET, 01/20/2017

Financials

Next reporting dateFebruary 14, 2017
EPS forecast (this quarter)$3.10
Annual revenue (last year)$4.1B
Annual profit (last year)$636.1M
Net profit margin15.50%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Scientific Officer
George Damis Yancopoulos
Chief Financial Officer &
Senior VP-Finance
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts


Search for Jobs